North American Vaccine (NVX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine (NVX)

NVX 1.130

+11.3%

11:26 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: andy harrison who wrote (1)	12/10/1996 9:20:00 PM
From: Don W Stone	of 35

Andy, I like this post and I whole heartedly agree with it. What Chiron Behring did apparently IMO was find the best way to satisfy a "strategic need" and NVX was the answer. I also think they went for a four year agreement with a right to extend it for three more years because they are not overly confident that they will have their own DTaP-IPV vaccine anytime soon. This is really a story about to competitors becoming partners because that is what works best for all concerned to include the two companies and their customers. I do have a lot of confidence in NVX management and their ability to enter into deals like this one so it certainly has my approval along with a congratuations to those who made it happen. Thanks. :-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next